Biomedical research at Oslo University Hospital
Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.
Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.
Click here to see hierarchical division and subunit overview
Summary of publications:
Publications (original articles or review articles) published in 2016 from OUS - Department of Urology
20 publications found
Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014
BMC Cancer, 16 (1), 799
DOI 10.1186/s12885-016-2832-x, PubMed 27737647
Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes
Urol Oncol, 35 (1), 35.e15-35.e19
DOI 10.1016/j.urolonc.2016.08.012, PubMed 27692834
Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study
BJU Int, 118 (3), 366-71
DOI 10.1111/bju.13410, PubMed 26765682
Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism
Oncotarget, 7 (2), 1878-94
DOI 10.18632/oncotarget.6479, PubMed 26646591
Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative
World J Urol, 35 (2), 221-228
DOI 10.1007/s00345-016-1867-6, PubMed 27246847
Asymptomatic Bacteriuria in Clinical Urological Practice: Preoperative Control of Bacteriuria and Management of Recurrent UTI
Pathogens, 5 (1)
DOI 10.3390/pathogens5010004, PubMed 26742080
Is Preoperative Assessment and Treatment of Asymptomatic Bacteriuria Necessary for Reducing the Risk of Postoperative Symptomatic Urinary Tract Infections After Urologic Surgical Procedures?
Urology, 99, 100-105
DOI 10.1016/j.urology.2016.10.016, PubMed 27773650
Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa-8 Study
Urology, 102, 138-142
DOI 10.1016/j.urology.2016.11.032, PubMed 27894979
Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26)
Scand J Urol, 50 (4), 280-5
DOI 10.3109/21681805.2016.1163617, PubMed 27049891
Urogenital Tuberculosis: Classification, Diagnosis, and Treatment
Eur. Urol. Suppl., 15 (4), 112-121
Observed correlation between the expression levels of catalytic subunit, Cβ2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness
Urol Oncol, 35 (3), 111.e1-111.e8
DOI 10.1016/j.urolonc.2016.10.002, PubMed 27838142
PBX3 is a putative biomarker of aggressive prostate cancer
Int J Cancer, 139 (8), 1810-20
DOI 10.1002/ijc.30220, PubMed 27273830
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer
Oncotarget, 7 (46), 74734-74746
DOI 10.18632/oncotarget.12543, PubMed 27732966
Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers
Eur J Cancer, 70, 122-132
DOI 10.1016/j.ejca.2016.10.011, PubMed 27914242
Letter to the Editor: Diagnostic Criteria in Urological Diseases do not Always Match with Findings by Extended Culture Techniques and Metagenomic Sequencing of 16S rDNA
Open Microbiol J, 10, 23-6
DOI 10.2174/1874285801610010023, PubMed 27006726
Improved Classification of Urinary Tract Infection: Future Considerations
Eur. Urol. Suppl., 15 (4), 71-80
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
Ann Oncol, 27 (7), 1299-304
DOI 10.1093/annonc/mdw164, PubMed 27052649
Management of Uncomplicated Recurrent Urinary Tract Infections
Eur. Urol. Suppl., 15 (4), 95-101
Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation
Eur J Pharm Sci, 98, 80-85
DOI 10.1016/j.ejps.2016.09.023, PubMed 27664330
Ability to Reach Orgasm in Patients With Prostate Cancer Treated With Robot-assisted Laparoscopic Prostatectomy
Urology, 92, 38-43
DOI 10.1016/j.urology.2015.11.066, PubMed 26972145